BNP Paribas Financial Markets’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,832
| Closed | -$475K | – | 5556 |
|
|
2025
Q2 | $475K | Sell |
4,832
-377
| -7% | -$35.7K | ﹤0.01% | 3357 |
|
|
2025
Q1 | $483K | Sell |
5,209
-1,301
| -20% | -$120K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $591K | Sell |
6,510
-660
| -9% | -$60.6K | ﹤0.01% | 3179 |
|
|
2024
Q3 | $692K | Sell |
7,170
-778
| -10% | -$75.9K | ﹤0.01% | 2699 |
|
|
2024
Q2 | $730K | Sell |
7,948
-4,102
| -34% | -$381K | ﹤0.01% | 2458 |
|
|
2024
Q1 | $1.11M | Buy |
12,050
+6,358
| +112% | +$596K | ﹤0.01% | 2427 |
|
|
2023
Q4 | $541K | Buy |
5,692
+2,421
| +74% | +$226K | ﹤0.01% | 2744 |
|
|
2023
Q3 | $306K | Sell |
3,271
-674
| -17% | -$62.3K | ﹤0.01% | 2951 |
|
|
2023
Q2 | $361K | Sell |
3,945
-2,578
| -40% | -$211K | ﹤0.01% | 2748 |
|
|
2023
Q1 | $480K | Sell |
6,523
-35,499
| -84% | -$3.07M | ﹤0.01% | 2761 |
|
|
2022
Q4 | $3.51M | Buy |
42,022
+7,225
| +21% | +$651K | 0.01% | 1491 |
|
|
2022
Q3 | $3.37M | Sell |
34,797
-79,000
| -69% | -$9.42M | 0.01% | 1583 |
|
|
2022
Q2 | $12M | Buy |
113,797
+96,587
| +561% | +$12.3M | 0.02% | 819 |
|
|
2022
Q1 | $2.97M | Sell |
17,210
-42,203
| -71% | -$6.31M | ﹤0.01% | 1581 |
|
|
2021
Q4 | $9.62M | Buy |
59,413
+48,734
| +456% | +$7.83M | 0.01% | 978 |
|
|
2021
Q3 | $1.59M | Buy |
10,679
+1,296
| +14% | +$269K | ﹤0.01% | 2055 |
|
|
2021
Q2 | $2.3M | Sell |
9,383
-2,567
| -21% | -$674K | ﹤0.01% | 1692 |
|
|
2021
Q1 | $3.16M | Buy |
11,950
+2,492
| +26% | +$703K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $2.77M | Sell |
9,458
-645
| -6% | -$165K | 0.01% | 1450 |
|
|
2020
Q3 | $2.39M | Sell |
10,103
-2,535
| -20% | -$576K | ﹤0.01% | 1430 |
|
|
2020
Q2 | $2.51M | Sell |
12,638
-6,872
| -35% | -$1.28M | ﹤0.01% | 1395 |
|
|
2020
Q1 | $3.58M | Buy |
19,510
+10,458
| +116% | +$1.86M | 0.01% | 1150 |
|
|
2019
Q4 | $1.51M | Buy |
9,052
+1,675
| +23% | +$249K | ﹤0.01% | 1823 |
|
|
2019
Q3 | $966K | Buy |
7,377
+2,250
| +44% | +$293K | ﹤0.01% | 1866 |
|
|
2019
Q2 | $622K | Sell |
5,127
-2,481
| -33% | -$294K | ﹤0.01% | 1906 |
|
|
2019
Q1 | $938K | Buy |
7,608
+3,311
| +77% | +$416K | ﹤0.01% | 1731 |
|
|
2018
Q4 | $503K | Buy |
4,297
+2,238
| +109% | +$264K | ﹤0.01% | 1803 |
|
|
2018
Q3 | $257K | Sell |
2,059
-2,875
| -58% | -$317K | ﹤0.01% | 2299 |
|
|
2018
Q2 | $422K | Sell |
4,934
-4,755
| -49% | -$349K | ﹤0.01% | 2081 |
|
|
2018
Q1 | $585K | Sell |
9,689
-2,565
| -21% | -$146K | ﹤0.01% | 2105 |
|
|
2017
Q4 | $646K | Sell |
12,254
-3,993
| -25% | -$210K | ﹤0.01% | 2297 |
|
|
2017
Q3 | $909K | Buy |
16,247
+4,682
| +40% | +$248K | ﹤0.01% | 1620 |
|
|
2017
Q2 | $726K | Buy |
11,565
+4,475
| +63% | +$261K | ﹤0.01% | 1703 |
|
|
2017
Q1 | $362K | Sell |
7,090
-2,076
| -23% | -$99K | ﹤0.01% | 1908 |
|
|
2016
Q4 | $391K | Buy |
9,166
+2,110
| +30% | +$89.7K | ﹤0.01% | 1816 |
|
|
2016
Q3 | $335K | Sell |
7,056
-3,909
| -36% | -$195K | ﹤0.01% | 1456 |
|
|
2016
Q2 | $554K | Buy |
10,965
+3,966
| +57% | +$200K | ﹤0.01% | 1466 |
|
|
2016
Q1 | $338K | Sell |
6,999
-6,501
| -48% | -$251K | ﹤0.01% | 1320 |
|
|
2015
Q4 | $531K | Buy |
13,500
+5,572
| +70% | +$223K | ﹤0.01% | 1338 |
|
|
2015
Q3 | $301K | Sell |
7,928
-178
| -2% | -$7.51K | ﹤0.01% | 1690 |
|
|
2015
Q2 | $322K | Sell |
8,106
-1,235
| -13% | -$38.5K | ﹤0.01% | 1509 |
|
|
2015
Q1 | $250K | Sell |
9,341
-12,020
| -56% | -$339K | ﹤0.01% | 1502 |
|
|
2014
Q4 | $627K | Sell |
21,361
-26,244
| -55% | -$648K | ﹤0.01% | 1068 |
|
|
2014
Q3 | $960K | Sell |
47,605
-173
| -0.4% | -$3.34K | ﹤0.01% | 1263 |
|
|
2014
Q2 | $800K | Buy |
47,778
+8,954
| +23% | +$127K | ﹤0.01% | 1287 |
|
|
2014
Q1 | $529K | Buy |
38,824
+34,008
| +706% | +$523K | ﹤0.01% | 1407 |
|
|
2013
Q4 | $70.5K | Buy |
+4,816
| New | +$77.5K | ﹤0.01% | 1787 |
|
|
2013
Q3 | – | Sell |
-10,590
| Closed | -$123K | – | 2568 |
|
|
2013
Q2 | $123K | Buy |
+10,590
| New | +$121K | ﹤0.01% | 2490 |
|
Other funds holding AMED
IA
MCI
HNB
BNP Paribas Financial Markets's AMED Position: Q3 2025 in Review
BNP Paribas Financial Markets sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,832 shares — an estimated $475K sold.
BNP Paribas Financial Markets first reported a position in AMED in Q2 2013 and held it in 48 quarters. The position peaked at $12M in Q2 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- BNP Paribas Financial Markets reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 4,832 Amedisys shares in Q3 2025, an estimated $475K.
- BNP Paribas Financial Markets first reported a position in Amedisys in Q2 2013 and held it in 48 quarters.
- BNP Paribas Financial Markets's Amedisys position peaked at $12M in Q2 2022.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.